CRISPR Therapeutics AG Live Stock Price Today, Share Analysis and Chart

Name: CRISPR Therapeutics AG: Is Infosys Ltd. worth buying?
Item: CRISPR Therapeutics AG
Rating: 1.08791675
Author: Trendlyne DVM scores

about

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

46.99 -0.79 (-1.65%)

40.12% Fall from 52W High

1.6M

XNAS Volume

XNAS 20 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.2 / 100

Technically Bearish

34.4 / 100

1Yr Price target upside is 81%

23 analysts

CRISPR Therapeutics AG Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

CRISPR Therapeutics AG Live Stock Price Today, Share Analysis and Chart

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revol...

40.12% Fall from 52W High

SWOT Analysis

CRISPR Therapeutics AG Live Price Chart

CRISPR Therapeutics AG Live Price Chart